Have a specific question about your LBP project? Click below and let’s get started.
#133L (Liquid)
Botulinum Neurotoxin Type A Toxoid from Clostridium botulinum
This product is discontinued.Purified neurotoxin is treated with formaldehyde to inactivate the toxin while maintaining epitopes which may be recognized by antibodies. The current lot of BoNT/A toxoid has been prepared using an optimized method for formaldehyde toxoiding. It has been tested for antigenicity and compared with the antigen reactivity of pure neurotoxin. It has been shown that the toxoid resembles the native toxin but is not toxic. Two botulinum toxin toxoids are available from List Labs.
Thesis
Lim, CYL;
Product: Botulinum Neurotoxin Type A Toxoid from Clostridium botulinum
Journal of Controlled Release
Torrisi, BM;Zarnitsyn, V;Prausnitz, MR;Anstey, A;Gateley, C;Birchall, JC;Coulman, SA;
Product: Botulinum Neurotoxin Type A Toxoid from Clostridium botulinum
October 2, 2018
By: List Labs
List Labs scours the internet monthly, looking for citations referencing our products. We are highly intrigued by, and love to investigate the different ways researchers use our products. Scientists world-wide have used our toxins for research and have produced interesting results. List Labs History of working with Botulinum Neurotoxin List Labs has developed sensitive assays […]
September 19, 2018
By: douano@listlabs.com
By: T.J. Smith The answer as to whether the botulinum neurotoxin (BoNT)-producing bacteria comprised six separate species required a complete revolution in microbial classification. Up to the turn of the last century, bacterial differentiations were based on morphological characteristic and biochemical activities, known collectively as phenotypic characteristics. However, the discovery of DNA as the ultimate […]
July 16, 2018
By: douano@listlabs.com
By: T.J. Smith Origins of Botulinum Toxin Types – relationships between toxins and the bacteria that produce them Soon after the discovery that botulism was caused by a toxin, multiple toxin types were identified. Initial characterizations were based mainly on serological differences, however other anomalies were noted, such as differences in toxicity, sensitivity or resistance […]
May 29, 2018
By: douano@listlabs.com
By: T.J. Smith Following a botulism outbreak due to contaminated ham that severely sickened 10 and resulted in the death of three people in Ellezelles, Belgium, a review and case study on botulism was published by a researcher named Emile Van Ermengem (Van Ermengem 1897). While Van Ermengem was not the first to study this […]
March 19, 2018
By: douano@listlabs.com
By: Mary N. Wessling, Ph.D. ELS List Biological Laboratories’ (List Labs) catalog of products is related to furthering research in human health and preventing disease, most commonly as the starting materials for vaccine research & development or production around the world. Vaccines are mainly identified for their capacity to prevent diseases that the body’s innate defensive […]
January 23, 2018
By: douano@listlabs.com
By: Rachel Berlin, Marketing Manager List Labs is proud to be exhibiting at ASM Biothreats February 12-14th. The conference will be held in Baltimore, Maryland at the Hilton Hotel. Thought leaders in academia, industry and government will gather to present and discuss the latest developments in the emerging field of biothreats. This year’s conference has […]
January 8, 2018
By: douano@listlabs.com
By: Rachel Berlin, Marketing Manager The List Labs website hosts a library of scientific article abstracts related to the research performed using our products called the Citations Page. Visitors can search this library to learn how others have used List Labs’ reagents in their research. This valuable resource is updated monthly with new articles from a wide variety […]
October 4, 2017
By: douano@listlabs.com
By: Shawn Lyles, Marketing Manager List Labs will be attending the 54th annual Interagency Botulism Research Coordinating Committee (IBRCC) this year from October 27-30th. The conference will be held in Ellicott City, MA at the Turf Valley Resort and Conference Center. This international forum presents state-of-the-art research on botulinum toxin and the deadly disease of […]
September 11, 2017
By: douano@listlabs.com
Over 20 Scientific Posters Available on our website Scientific posters are a great way to visually display complex scientific issues. List Labs has a large list of scientific posters published on our website under the specific products they pertain to. We have been getting a lot of requests lately to compile a list of all […]
April 7, 2014
By: dpinkston@listlabs.com
List Biological Laboratories, Inc. (List) actively supports and participates in the BabyBIG® project. What is BabyBIG® ? BabyBIG® (Human Botulism Immune Globulin; BIG-IV) is a public service, not-for-profit orphan drug manufactured and distributed by the California Department of Public Health.It is the only therapy available for infants who are infected with the organism that causes […]
Have a specific question about your LBP project? Click below and let’s get started.
List Labs
540 Division Street
Campbell, California
List Biotherapeutics
9800 Crosspoint BIvd Suite 2011
Indianapolis, IN 46256, USA